New XIAFLEX Findings Shared at Medical Conference
Researchers presented data on a Peyronie's disease treatment and a new sexual health screening tool for patients.
Updated on Oct. 8, 2026 in Men’s Health
Live Poll
Do you trust pharmaceutical companies to provide accurate tools for discussing your personal health concerns?
Keenova Therapeutics shared three presentations at the Sexual Medicine Society of North America annual meeting regarding their treatment for Peyronie's disease. The sessions also highlighted a new tool designed to assist clinicians in the assessment of sexual health concerns.
Why it matters
Peyronie's disease, which causes a buildup of fibrous scar tissue and penile curvature, affects an estimated 1 in 10 men in the U.S. These findings aim to improve the efficiency of identifying symptoms and understanding treatment options for those impacted.
Data presented at the conference included findings from a survey of 7,700 men and clinical trial results for XIAFLEX. It remains unknown how the newly debuted screening tool will affect rates of diagnosis in primary care settings.
The players
Keenova Therapeutics
A Dublin-based pharmaceutical company focused on the development of therapies for men's sexual health, including XIAFLEX.
Sexual Medicine Society of North America
A professional medical society dedicated to the advancement of sexual medicine through research, education, and clinical practice standards.
The details
XIAFLEX works by being injected directly into the Peyronie's plaque, the area of fibrous scar tissue causing the curvature. Clinical trials have reported side effects including penile hematoma in 65.5% of patients and ecchymosis in 14.5% of patients. The new sexual health screening tool is designed to help clinicians more efficiently initiate conversations about sexual health and specific symptoms like curvature.
Timeline
The Sexual Medicine Society of North America annual meeting took place from October 8-11, 2026.
Health Landscape
These presentations were featured at the Sexual Medicine Society of North America annual meeting, a central forum for urological research. The findings align with ongoing efforts to standardize the identification and treatment of Peyronie's disease in the clinical landscape.
If you are concerned about symptoms like penile curvature, it is worth discussing the Men's Sexual Health Screener with your primary care physician or a urologist. This conversation can help you determine if you meet the clinical criteria for further assessment.
The takeaway
Peyronie's disease is a common condition involving scar tissue that may require clinical intervention if curvature exceeds 30 degrees. If you suspect symptoms, prioritize an evaluation with a specialist who can discuss the risks and benefits of available medical therapies.
Further reading
For more information on current treatment trends, visit the Men’s Health section.
Source note: This article includes information reported by Firstwordpharma.
Live Poll
Do you trust pharmaceutical companies to provide accurate tools for discussing your personal health concerns?
